Structure-based screening and optimization of cytisine derivatives as inhibitors of the menin-MLL interaction

被引：27
|
作者：
Zhong, Hai-Jing [1 ]
Lee, Bo Ra [3 ]
Boyle, Joshua William [3 ]
Wang, Wanhe [2 ]
Ma, Dik-Lung [2 ]
Chan, Philip Wai Hong [3 ,4 ]
Leung, Chung-Hang [1 ]
机构：
[1] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau, Peoples R China
[2] Hong Kong Baptist Univ, Dept Chem, Kowloon Tong, Hong Kong, Peoples R China
[3] Monash Univ, Sch Chem, Clayton, Vic 3800, Australia
[4] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England
来源：
CHEMICAL COMMUNICATIONS | 2016年 / 52卷 / 34期
基金：
澳大利亚研究理事会; 中国国家自然科学基金;
关键词：
HISTONE MODIFICATIONS; LEUKEMIA; PROTEINS; DISCOVERY; FAMILY; CANCER; GENES; SET1;
D O I：
10.1039/c6cc01079b
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
The natural product-like compound 1 was identified as a direct inhibitor of the menin-MLL interaction by in silico screening. Structure-based optimization furnished analogue 1a, which showed significantly higher potency than both the lead structure 1 and the reference compound MI-2.
引用
收藏
页码：5788 / 5791
页数：4
相关论文
共 50 条
  • [21] High-affinity small molecule inhibitors of the menin-MLL interaction reverse oncogenic transformation mediated by MLL fusion proteins in leukemia
    Grembecka, Jolanta E.
    He, Shihan
    Senter, Timothy J.
    Borkin, Dmitry
    Pollock, Jonathan
    Han, Changho
    Upadhyay, Sunil Kumar
    Purohit, Trupta
    Miao, Hongzhi
    Gogliotti, Rocco D. D. Gogliotti
    Lindsley, Craig W.
    Cierpicki, Tomasz
    Stauffer, Shaun R.
    CANCER RESEARCH, 2014, 74 (19)
  • [22] Disruption of the menin-MLL interaction triggers menin protein degradation via ubiquitin-proteasome pathway
    Wu, Yuan
    Doepner, Miriam
    Hojnacki, Taylor
    Feng, Zijie
    Katona, Bryson W.
    He, Xin
    Ma, Jian
    Cao, Yan
    Busino, Luca
    Zhou, Fuxiang
    Hua, Xianxin
    AMERICAN JOURNAL OF CANCER RESEARCH, 2019, 9 (08): : 1682 - 1694
  • [23] Menin-MLL inhibitors block oncogenic transformation by MLL-fusion proteins in a fusion partner-independent manner
    S He
    B Malik
    D Borkin
    H Miao
    S Shukla
    K Kempinska
    T Purohit
    J Wang
    L Chen
    B Parkin
    S N Malek
    G Danet-Desnoyers
    A G Muntean
    T Cierpicki
    J Grembecka
    Leukemia, 2016, 30 : 508 - 513
  • [24] Menin-MLL inhibitors block oncogenic transformation by MLL-fusion proteins in a fusion partner-independent manner
    He, S.
    Malik, B.
    Borkin, D.
    Miao, H.
    Shukla, S.
    Kempinska, K.
    Purohit, T.
    Wang, J.
    Chen, L.
    Parking, B.
    Malek, S. N.
    Danet-Desnoyers, G.
    Muntean, A. G.
    Cierpicki, T.
    Grembecka, J.
    LEUKEMIA, 2016, 30 (02) : 508 - 513
  • [25] An organoid-based drug screening identified a menin-MLL inhibitor for endometrial cancer through regulating the HIF pathway
    Chen, Jingyao
    Zhao, Lei
    Peng, Hongling
    Dai, Siqi
    Quan, Yuan
    Wang, Manli
    Wang, Jian
    Bi, Zhanying
    Zheng, Ying
    Zhou, Shengtao
    Liu, Yu
    Chen, Chong
    Na, Feifei
    CANCER GENE THERAPY, 2021, 28 (1-2) : 112 - 125
  • [26] An organoid-based drug screening identified a menin-MLL inhibitor for endometrial cancer through regulating the HIF pathway
    Jingyao Chen
    Lei Zhao
    Hongling Peng
    Siqi Dai
    Yuan Quan
    Manli Wang
    Jian Wang
    Zhanying Bi
    Ying Zheng
    Shengtao Zhou
    Yu Liu
    Chong Chen
    Feifei Na
    Cancer Gene Therapy, 2021, 28 : 112 - 125
  • [27] Structure-based optimization of novel azepane derivatives as PKB inhibitors
    Breitenlechner, CB
    Wegge, T
    Berillon, L
    Graul, K
    Marzenell, M
    Friebe, WG
    Thomas, U
    Schumacher, R
    Huber, R
    Engh, RA
    Masjost, B
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (06) : 1375 - 1390
  • [28] Discovery of novel menin-MLL small molecule inhibitors that display high potency and selectivity in vitro and in vivo
    Kessler, L.
    Wu, T.
    Grembecka, J.
    Cierpicki, T.
    Purohit, T.
    Miao, H.
    Kempinska, K.
    Ely, T.
    Hensen, R.
    Li, S.
    Patricelli, M.
    Li, S.
    Kucharski, J.
    Zhang, J.
    Yao, Y.
    Yu, K.
    Wang, Y.
    Li, L.
    Ren, P.
    Liu, Y.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S88 - S88
  • [29] Diphenyl Urea Derivatives as Inhibitors of Transketolase: A Structure-Based Virtual Screening
    Obiol-Pardo, Cristian
    Alcarraz-Vizan, Gema
    Cascante, Marta
    Rubio-Martinez, Jaime
    PLOS ONE, 2012, 7 (03):
  • [30] Discovery of selective BPTF bromodomain inhibitors by screening and structure-based optimization
    Xiong, Liang
    Mao, Xin
    Guo, Yinping
    Zhou, Yangli
    Chen, Mingxin
    Chen, Pei
    Yang, Shengyong
    Li, Linli
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 545 : 125 - 131
12345